Distinct Signature of Oxylipid Mediators of Inflammation during Infection and Asymptomatic Colonization by in the Urinary Bladder.

Nandakumar Packiriswamy, Jeff Gandy, Sara N Smith, Harry L T Mobley, Lorraine M Sordillo, Sargurunathan Subashchandrabose
Author Information
  1. Nandakumar Packiriswamy: Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI, USA.
  2. Jeff Gandy: Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI, USA.
  3. Sara N Smith: Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.
  4. Harry L T Mobley: Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.
  5. Lorraine M Sordillo: Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI, USA. ORCID
  6. Sargurunathan Subashchandrabose: Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston-Salem, NC, USA. ORCID

Abstract

Urinary tract infection (UTI) is an extremely common infectious disease. Uropathogenic (UPEC) is the predominant etiological agent of UTI. Asymptomatic bacteriuric (ABEC) strains successfully colonize the urinary tract resulting in asymptomatic bacteriuria (ABU) and do not induce symptoms associated with UTI. Oxylipids are key signaling molecules involved in inflammation. Based on the distinct clinical outcomes of colonization, we hypothesized that UPEC triggers the production of predominantly proinflammatory oxylipids and ABEC leads to production of primarily anti-inflammatory or proresolving oxylipids in the urinary tract. We performed quantitative detection of 39 oxylipid mediators with proinflammatory, anti-inflammatory, and proresolving properties, during UTI and ABU caused by genetically distinct strains in the murine urinary bladder. Our results reveal that infection with UPEC causes an increased accumulation of proinflammatory oxylipids as early as 6 h postinoculation, compared to controls. To the contrary, ABEC colonization leads to decreased accumulation of proinflammatory oxylipids at the early time point compared to UPEC infection but does not affect the level of proresolving oxylipids. This report represents the first comprehensive investigation on the oxylipidome during benign ABEC colonization observed in ABU and acute inflammation triggered by UPEC leading to UTI.

References

  1. Nature. 2012 Apr 25;484(7395):524-8 [PMID: 22538616]
  2. Clin Infect Dis. 2011 Mar 1;52(5):e103-20 [PMID: 21292654]
  3. Infect Immun. 2006 Jan;74(1):781-5 [PMID: 16369040]
  4. J Dairy Sci. 2017 Mar;100(3):1870-1887 [PMID: 28109600]
  5. Semin Immunol. 2013 Oct 31;25(3):240-8 [PMID: 24084369]
  6. J Urol. 2002 Oct;168(4 Pt 1):1568-73 [PMID: 12352459]
  7. J Infect Dis. 2010 Apr 15;201(8):1240-9 [PMID: 20225955]
  8. BMJ. 2015 Dec 23;351:h6544 [PMID: 26698878]
  9. Cell Microbiol. 2008 Dec;10(12):2568-78 [PMID: 18754853]
  10. Infect Immun. 2017 Jan 26;85(2): [PMID: 27895127]
  11. Mediators Inflamm. 2016;2016:9867138 [PMID: 27818578]
  12. Nat Rev Urol. 2010 Dec;7(12):653-60 [PMID: 21139641]
  13. FEMS Microbiol Lett. 2013 Sep;346(1):1-10 [PMID: 23808987]
  14. Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:95-114 [PMID: 12432912]
  15. Cell. 2010 Mar 5;140(5):717-30 [PMID: 20211140]
  16. Clin Infect Dis. 2013 Nov;57(9):1256-65 [PMID: 23926176]
  17. J Biol Chem. 2009 Aug 7;284(32):21599-612 [PMID: 19487688]
  18. Nat Protoc. 2009;4(8):1230-43 [PMID: 19644462]
  19. Antimicrob Agents Chemother. 2016 Jun 20;60(7):4420-1 [PMID: 27230792]
  20. Nat Rev Immunol. 2015 Aug;15(8):511-23 [PMID: 26139350]
  21. Am J Ther. 2005 Jan-Feb;12(1):46-55 [PMID: 15662292]
  22. J Infect Dis. 2001 Mar 1;183 Suppl 1:S1-4 [PMID: 11171002]
  23. Am J Physiol Renal Physiol. 2005 Jul;289(1):F49-60 [PMID: 15741608]
  24. Microbiol Spectr. 2016 Jun;4(3): [PMID: 27337480]
  25. J Urol. 2002 Jun;167(6):2603-12 [PMID: 11992095]
  26. Cell Microbiol. 2011 Nov;13(11):1703-13 [PMID: 21790943]
  27. Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9772-7 [PMID: 15994227]
  28. Microbiol Spectr. 2015 Aug;3(4):null [PMID: 26350328]
  29. J Pediatr. 1978 Feb;92(2):194-9 [PMID: 340626]
  30. J Immunol. 2012 Jan 15;188(2):781-92 [PMID: 22184725]
  31. Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18327-32 [PMID: 25489107]
  32. EBioMedicine. 2014 Oct 24;1(1):46-57 [PMID: 26125048]
  33. Crit Rev Microbiol. 2016 Sep;42(5):780-99 [PMID: 26006172]
  34. N Engl J Med. 2012 Mar 15;366(11):1028-37 [PMID: 22417256]
  35. Infect Dis Clin North Am. 2014 Mar;28(1):1-13 [PMID: 24484571]
  36. Cell. 2013 Jul 3;154(1):213-27 [PMID: 23827684]
  37. BMC Infect Dis. 2012 Jun 28;12:146 [PMID: 22742538]
  38. Infect Immun. 1990 May;58(5):1281-9 [PMID: 2182540]
  39. Antimicrob Agents Chemother. 2002 Aug;46(8):2540-5 [PMID: 12121930]
  40. Infect Immun. 2010 Feb;78(2):568-85 [PMID: 19917708]
  41. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4 [PMID: 12471157]
  42. Kidney Int. 2001 Mar;59(3):893-904 [PMID: 11231344]
  43. Infect Immun. 1991 Sep;59(9):2915-21 [PMID: 1879917]

Grants

  1. R01 AI116791/NIAID NIH HHS
  2. R01 DK094777/NIDDK NIH HHS

MeSH Term

Animals
Escherichia coli Infections
Fatty Acids
Female
Inflammation Mediators
Lipids
Lipoxygenase
Mice
Mice, Inbred CBA
Prostaglandin-Endoperoxide Synthases
Urinary Bladder
Urinary Tract Infections

Chemicals

Fatty Acids
Inflammation Mediators
Lipids
Lipoxygenase
Prostaglandin-Endoperoxide Synthases

Word Cloud

Created with Highcharts 10.0.0UTIUPECoxylipidsABECproinflammatorytractinfectionurinaryABUcolonizationproresolvingUrinaryAsymptomaticstrainsinflammationdistinctproductionleadsanti-inflammatoryaccumulationearlycomparedextremelycommoninfectiousdiseaseUropathogenicpredominantetiologicalagentbacteriuricsuccessfullycolonizeresultingasymptomaticbacteriuriainducesymptomsassociatedOxylipidskeysignalingmoleculesinvolvedBasedclinicaloutcomeshypothesizedtriggerspredominantlyprimarilyperformedquantitativedetection39oxylipidmediatorspropertiescausedgeneticallymurinebladderresultsrevealcausesincreased6 hpostinoculationcontrolscontrarydecreasedtimepointaffectlevelreportrepresentsfirstcomprehensiveinvestigationoxylipidomebenignobservedacutetriggeredleadingDistinctSignatureOxylipidMediatorsInflammationInfectionColonizationBladder

Similar Articles

Cited By